Banque Pictet & Cie’s Pacific Biosciences PACB Stock Holding History

Banque Pictet & Cie’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-400,722	Closed	-$3.65M	–	664
2022 Q1	$3.65M	Sell	400,722 -3,634	-0.9%	-$41.8K	0.03%	226
2021 Q4	$8.27M	Buy	404,356 +358,013	+773%	+$8.64M	0.06%	152
2021 Q3	$1.18M	Buy	46,343 +13,758	+42%	+$408K	0.01%	245
2021 Q2	$1.14M	Buy	32,585 +1,507	+5%	+$43.8K	0.01%	251
2021 Q1	$1.03M	Buy	+31,078	New	+$1.09M	0.01%	245

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Banque Pictet & Cie's PACB Position: Q2 2022 in Review

Banque Pictet & Cie sold out of Pacific Biosciences (PACB) in Q2 2022, closing a stake of 400,722 shares — an estimated $3.65M sold.

Banque Pictet & Cie first reported a position in PACB in Q1 2021 and held it in 5 quarters. The position peaked at $8.27M in Q4 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q2 2022.

Banque Pictet & Cie reported no remaining Pacific Biosciences position as of Q2 2022 after selling out during the quarter.
Banque Pictet & Cie sold 400,722 Pacific Biosciences shares in Q2 2022, an estimated $3.65M.
Banque Pictet & Cie first reported a position in Pacific Biosciences in Q1 2021 and held it in 5 quarters.
Banque Pictet & Cie's Pacific Biosciences position peaked at $8.27M in Q4 2021.
229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2022.

Based on Banque Pictet & Cie's 13F filing for Q2 2022, filed 8 Aug 2022.